Sunday, November 26, 2023

Natural Immunity Better Than Protection From COVID-19 Vaccination

People with protection against COVID-19 following recovery from the illness were better protected than those who received a COVID-19 vaccine, according to a new study.

"Our study showed that natural immunity offers stronger and longer-lasting protection against infection, symptoms, and hospitalization compared to vaccine-induced immunity," Dr. Anneli Uusküla, with the Department of Family Medicine and Public Health at the University of Tartu, and her co-authors wrote.

One compared people with natural immunity to those who received a vaccine; one compared the naturally immune to people who did not have documented prior infection or vaccination; and one compared the naturally immune to people with hybrid immunity, or both prior infection and vaccination.

The primary outcome was laboratory-confirmed COVID-19 occurring at any time for people without any immunity, after 60 days of recovery from a prior infection for the naturally immune, at least 14 days after completion of a vaccine for the vaccinated group, and at least 14 days after vaccination or 60 days after recovery for people with hybrid immunity.

In the cohort comparing the naturally immune to people without prior immunity or vaccination, researchers found that the naturally immune were much better protected against hospitalization, used as a measure of protection against severe disease.

"During both periods, natural immunity proved to be highly effective in protecting against reinfections progressing to severe disease and was associated with a significantly lower risk of COVID hospitalization than no SARS-CoV-2-specific immunity," the researchers said.

"Irrespective of the infection-causing variant, the protective effect of hybrid immunity in preventing infection progression to severe COVID-19 significantly exceeded that of natural immunity," the authors said. 

https://www.theepochtimes.com/health/natural-immunity-better-than-protection-from-covid-19-vaccination-study-5534822?utm_source=partner&utm_campaign=ZeroHedge&src_src=partner&src_cmp=ZeroHedge

No comments: